StonvexLoading…
StonvexStonvexStonvexCore line items from GMHS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-06-30 | Annual 2024 2024-06-30 | Annual 2023 2023-06-30 |
|---|---|---|---|
Revenue | $118.05M | $145.24M | $168.16M |
Operating Income | $3.39M | $8.35M | $3.15M |
Net Income | $3.96M | $8.25M | $3.79M |
EPS (Diluted) | $0.08 | $0.16 | $0.08 |
Total Assets | $47.21M | $51.28M | $55.72M |
Total Liabilities | $14.10M | $17.24M | $30.16M |
Cash & Equivalents | $15.23M | $18.82M | $16.01M |
Free Cash Flow OCF − CapEx | $2.18M | $4.36M | $2.46M |
Shares Outstanding | 51.54M | 75.41M | 75.41M |